Sushil Beriwal, Vice President Varian Medical Affairs, shared a post on LinkedIn:
“Talking about barriers and challenges in rad Onc and potential solutions along with support and funding for multiple prospective studies by Varian for adaptive and other indications to help generate evidence.”
More from Sushil Beriwal on OncoDaily.